Savvy Advisors Inc’s Biogen BIIB Stock Holding History

Savvy Advisors Inc’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$863K	Buy	3,996 +132	+3%	+$25.3K	0.02%	569
2026 Q1	$708K	Sell	3,864 -385	-9%	-$70.9K	0.02%	546
2025 Q4	$748K	Buy	4,249 +811	+24%	+$132K	0.02%	436
2025 Q3	$482K	Buy	3,438 +373	+12%	+$50.4K	0.02%	436
2025 Q2	$385K	Buy	+3,065	New	+$382K	0.03%	425

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Savvy Advisors Inc's BIIB Position: Q2 2026 in Review

Savvy Advisors Inc increased its Biogen (BIIB) stake by 3.4% in Q2 2026, buying an estimated $25.3K and bringing the position to 3,996 shares worth $863K. The position accounts for 0.02% of the portfolio, ranked #569.

Savvy Advisors Inc first reported a position in BIIB in Q2 2025 and has held it in 5 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Savvy Advisors Inc held 3,996 shares of Biogen worth $863K as of Q2 2026.
Savvy Advisors Inc bought 132 Biogen shares in Q2 2026, an estimated $25.3K.
Biogen made up 0.02% of Savvy Advisors Inc's portfolio in Q2 2026, its #569 holding.
Savvy Advisors Inc first reported a position in Biogen in Q2 2025 and has held it in 5 quarters since.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.